Special guest Deanna L. McDanel, PharmD, BCPS, BCACP, Clinical Pharmacy Specialist - Ambulatory Care and Clinical Associate Professor at the University of Iowa Healthcare and College of Pharmacy joins us to talk about penicillin allergies.

Listen in as they discuss how to identify the risk of a true penicillin allergy...and when to worry about cross-reactivity.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Stephen Carek, MD, CAQSM, DipABLM, Clinical Assistant Professor, Family Medicine, Prisma Health/USC-SOMG Family Medicine Residency Program at the USC School of Medicine Greenville
• Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
• Douglas S. Paauw, MD, MACP, Professor of Medicine at the University of Washington School of Medicine
• Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science University

None of the speakers have anything to disclose. 

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com. 

Special guest Steven E. Nissen, MD, MACC, the Chief Academic Officer at the Heart and Vascular Institute, Lewis and Patricia Dickey Chair in Cardiovascular Medicine, and Professor of Medicine at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve University joins us to talk about non-statins for LDL lowering.

Listen in as they debate which non-statin to use for LDL lowering...due to recent headlines about bempedoic acid.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Reid B. Blackwelder, MD, FAAFP, Associate Dean of Graduate and Continuing Medical Education at East Tennessee State University
• Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor Health
• Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
• Douglas S. Paauw, MD, MACP, Professor of Medicine at the University of Washington School of Medicine
• Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science University

For the purposes of disclosure, Dr. Steven Nissen reports relevant financial relationships [cardiology] with AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Esperion, Medtronic, MyoKardia, New Amsterdam Pharma, Novartis, Pfizer, Silence Therapeutics (grants/research support). The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com. 

Special guest Nicole Gastala, MD, Assistant Professor from the University of Illinois Chicago Department of Family Medicine and Director of Behavioral Health and Addiction at the Mile Square Health Center joins us to talk about opioid use disorder.

Listen in as they discuss big changes with buprenorphine prescribing for opioid use disorder.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor Health
• Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
• Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science University

None of the speakers have anything to disclose.

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com.

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com. 

Special guest Steven E. Nissen, MD, MACC, the Chief Academic Officer at the Heart and Vascular Institute, Lewis and Patricia Dickey Chair in Cardiovascular Medicine, and Professor of Medicine at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve University joins us to talk about medications for type 2 diabetes.

Listen in as they debate whether metformin should still be first-line for all patients with type 2 diabetes...and discuss the role of GLP-1 agonists and SGLT2 inhibitors in these patients.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Reid B. Blackwelder, MD, FAAFP, Associate Dean of Graduate and Continuing Medical Education at East Tennessee State University
• Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
• Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science University

For the purposes of disclosure, Dr. Steven Nissen reports a relevant financial relationship with AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Esperion, Medtronic, Novartis, Pfizer, Silence Therapeutics (grants/research support). The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com. 

Special guest Laila Khalid, MD, MPH from the Albert Einstein College of Medicine Montefiore Medical Center joins us to talk about new guidelines to reinforce safe opioid use.

Listen in as they discuss what’s changed with the updated CDC opioid guidelines...and what to expect in your practice.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor Health
• Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
• Joseph Scherger, MD, MPH, Family Physician, Primary Care 365, Eisenhower Health

None of the speakers have anything to disclose.

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com.

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com. 

Headache medicine specialist Rebecca C. Burch, MD, joins us to talk about triptan use in patients with cardiovascular risk factors.

Listen in as they clear up confusion about which patients should avoid triptans due to cardiovascular concerns.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
• Steven E. Nissen, MD, MACC, the Chief Academic Officer at the Heart and Vascular Institute and the Lewis and Patricia Dickey Chair in Cardiovascular Medicine Professor of Medicine at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve University
• Joseph Scherger, MD, MPH, Family Physician, Primary Care 365, Eisenhower Health
• Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science University

For the purposes of disclosure, Dr. Steven Nissen reports a relevant financial relationship with AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Esperion, Medtronic, Novartis, Pfizer, Silence Therapeutics (grants/research support). The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com.

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com. 

Special guest Carolyn J. Crandall, MD, MS, MACP, Professor of Medicine at the University of California, Los Angeles School of Medicine joins us to talk about hormone therapy for menopausal symptoms.

Listen in as they clarify when and how to use hormone therapy to manage menopausal symptoms.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Reid B. Blackwelder, MD, FAAFP, Associate Dean of Graduate and Continuing Medical Education at East Tennessee State University
• Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor Health
•  Steven E. Nissen, MD, MACC, the Chief Academic Officer at the Heart and Vascular Institute and the Lewis and Patricia Dickey Chair in Cardiovascular Medicine Professor of Medicine at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve University

For the purposes of disclosure, Dr. Steven Nissen reports a relevant financial relationship with AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Esperion, Medtronic, Novartis, Pfizer, Silence Therapeutics (grants/research support). The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com. 

TRC Editor, Dr. Lori Dickerson, PharmD, FCCP talks with Dr. Richard H. Dang, PharmD, APh, BCACP, FCPhA, from the University of Southern California and Dr. Elisha Hall, PhD, RD, from the COVID-19 Vaccine Policy Unit at the Centers for Disease Control and Prevention about COVID-19 vaccine boosters.

Listen in as they answer your top questions about updated COVID-19 vaccine boosters.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor Health
• Douglas S. Paauw, MD, MACP, Professor of Medicine at the University of Washington School of Medicine
• Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science University

None of the speakers have anything to disclose. 

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com. 

TRC Editor, Dr. Lori Dickerson, PharmD, FCCP talks with Douglas S. Paauw, MD, MACP, Professor of Medicine from the University of Washington School of Medicine about serotonin syndrome.

Listen in as they discuss how to tease out which serotonin syndrome interaction alerts are clinically significant.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Reid B. Blackwelder, MD, FAAFP, Associate Dean of Graduate and Continuing Medical Education at East Tennessee State University
• Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor Health
• Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
• Joseph Scherger, MD, MPH, Family Physician, Primary Care 365, Eisenhower Health
• Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science University

None of the speakers have anything to disclose. 

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com. 

TRC Editor, Dr. Lori Dickerson, PharmD, FCCP talks with Joseph Saseen, PharmD, FCCP, FNLA, Associate Dean for Clinical Affairs, Professor, Department of Clinical Pharmacy and Professor, Department of Family Medicine from the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus about managing statin intolerance. 

Listen in as they discuss how to evaluate statin-associated muscle pain...and review strategies to help patients take a statin successfully. 

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor Health
• Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
• Steven E. Nissen, MD, MACC, the Chief Academic Officer at the Heart and Vascular Institute and the Lewis and Patricia Dickey Chair in Cardiovascular Medicine Professor of Medicine at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve University
• Joseph Scherger, MD, MPH, Family Physician, Primary Care 365, Eisenhower Health
• Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science University

For the purposes of disclosure, Dr. Steven Nissen reports a relevant financial relationship with AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Esperion, Medtronic, Novartis, Pfizer, Silence Therapeutics (grants/research support).

The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com. 

TRC Editor, Dr. Lori Dickerson, PharmD, FCCP talks with Kenneth Cusi, MD, FACP, FACE,  Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism from The University of Florida about managing nonalcoholic fatty liver disease.

Listen in as they discuss considerations with managing nonalcoholic fatty liver disease (NAFLD)...including risk factors, screening, and treatment options.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
• Douglas S. Paauw, MD, MACP, Professor of Medicine at the University of Washington School of Medicine
• Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science University

For the purposes of disclosure, Dr. Cusi reports relevant financial relationships with Echosens, Inventiva, Nordic Pharma, Novo Nordisk, Poxel, Zydus (grants/research support); Ionis, Janssen, Genentech, Gilead, Madrigal, Merck, Novo Nordisk, Pfizer, Poxel, Terns Pharmaceuticals (consultant). The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com. 

TRC Editor, Dr. Lori Dickerson, PharmD, FCCP talks with Dr. Russ Blackwelder, MD, MDiv, CMD,  Associate Professor and Director of Geriatric Education from the MUSC Department of Family Medicine and Co-Medical Director from The Village at Summerville about managing agitation in patients with dementia.

Listen in as they discuss practical strategies for managing agitation in patients with dementia...and clarify pros and cons of various medications.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor Health
• Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
• Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science University

None of the speakers have anything to disclose. 

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com. 

TRC Editor, Dr. Lori Dickerson, PharmD, FCCP talks with Dr. Dwight Blair, MD, Inpatient Palliative Care Consultant from Lower Cape Fear Lifecare and New Hanover Regional Medical Center about meds for end-of-life care.

Listen in as they discuss unique med considerations for patients at the end of life...and how to help fine-tune meds for these patients.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor Health
• Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
• Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science University

None of the speakers have anything to disclose. 

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com. 

TRC Editor, Dr. Lori Dickerson, PharmD, FCCP talks with two distinguished experts about new heart failure guidelines. 

• Carolyn Lam, MBBS, PhD, FRCP, Professor at Duke-NUS Medical School and a Senior Consultant at the National Heart Centre Singapore
• Steven E. Nissen, MD, MACC, the Chief Academic Officer at the Heart and Vascular Institute and the Lewis and Patricia Dickey Chair in Cardiovascular Medicine Professor of Medicine at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve University

Listen in as they discuss new guidelines for managing heart failure with reduced ejection fraction (HFrEF)...and put this new guidance in perspective.

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor Health
• Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
• Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science University

For the purposes of disclosure, Dr. Carolyn Lam reports relevant financial relationships with Bayer, Roche Diagnostics (grants/research support); Abbott, Actelion, Alleviant Medical, Allysta Pharmaceuticals, Amgen, AnaCardio AB, Applied Therapeutics, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Cytokinetics, Darma Inc., EchoNous Inc, Impulse Dynamics, Ionis Pharmaceuticals, Janssen, Merck, Novartis, Novo Nordisk, Roche Diagnostics, Sanofi, Siemens Healthcare Diagnostics, Us2.ai (advisory board/steering committee/executive committee); Us2.ai (stock shareholder); Us2.ai (non-executive director).

Dr. Steven Nissen reports a relevant financial relationship with AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Esperion, Medtronic, Novartis, Pfizer, Silence Therapeutics (grants/research support).

The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com. 

TRC Editor, Dr. Lori Dickerson, PharmD, FCCP talks with Chelsey McIntyre, PharmD, Managing Editor of TRC’s Natural Medicines about homeopathy.

She’ll help clear up confusion about what homeopathic products are...and aren’t...and how they compare to supplements. 

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Reid B. Blackwelder, MD, FAAFP, Associate Dean of Graduate and Continuing Medical Education at East Tennessee State University
• Andrea Darby-Stewart, MD, Associate Director, Family Medicine Residency at Honor Health
• Douglas S. Paauw, MD, MACP, Professor of Medicine at the University of Washington School of Medicine
• Joseph Scherger, MD, MPH, Family Physician, Primary Care 365, Eisenhower Health

None of the speakers, panelists, or staff you’ll hear in this episode have anything to disclose. 

Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 

Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com. 

TRC Healthcare, home of Pharmacist's Letter and Prescriber's Letter, is excited to announce a brand-new way to get our concise, actionable, unbiased information about the latest developments in medication therapy. 

https://trchealthcare.com/